Role of cyclooxygenase-2, but not cyclooxygenase-1, on type II collagen-induced arthritis in DBA/1J mice (Q44578164)

4 December 2017

Role of cyclooxygenase-2, but not cyclooxygenase-1, on type II collagen-induced arthritis in DBA/1J mice (English)

1 reference

4 December 2017

Takehiro Ochi

1

1 reference

4 December 2017

Yoshitaka Ohkubo

series ordinal

2

1 reference

4 December 2017

Seitaro Mutoh

series ordinal

3

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

Biochemical Pharmacology

1 reference

4 December 2017

66

1 reference

4 December 2017

6

1 reference

4 December 2017

1055-1060

1 reference

Human cyclooxygenase-2 cDNA

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Serum transfer of collagen-induced arthritis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Effects of indomethacin, cyclosporin, cyclophosphamide, and placebo on collagen-induced arthritis of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Studies on type II collagen induced arthritis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Effect of etodolac on type-II collagen-induced arthritis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Anti-inflammatory and analgesic effects of a novel pyrazole derivative, FR140423

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Pharmacological analysis of cyclooxygenase-1 in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Ethical guidelines for investigations of experimental pain in conscious animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Pharmacological modulation of eicosanoid levels and hyperalgesia in yeast-induced inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

58 Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Anti-inflammatory effect of FR140423, a novel selective cyclo-oxygenase-2 inhibitor, in rat adjuvant arthritis without gastrointestinal side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Reduced susceptibility to collagen-induced arthritis in DBA/1J mice expressing the TSG-6 transgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Enhanced production of interleukin-6 in mice with type II collagen-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Interleukin 6 is required for the development of collagen-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Induction of cyclooxygenase II in human synovial microvessel endothelial cells by interleukin-1. Inhibition by glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

Anti-inflammatory activity of a novel selective cyclooxygenase-2 inhibitor, FR140423, on type II collagen-induced arthritis in Lewis rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900420-9

10.1016/S0006-2952(03)00420-9

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference